Hospital Universitatrio Puerta del Hierro

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2	Extensive Stage Lung Small Cell Cancer	Recruiting	Phase 2	2026-09-21		NCT07203053

Clinical trials